Increased constituent ratios of Klebsiella sp., Acinetobacter sp., and Streptococcus sp. and a decrease in microflora

Wei Lu1, Jialin Yu1, Qing Ai2

  • 1Department of Neonatology, Children's Hospital of Chongqing Medical University, Chongqing, China ; Pediatrics Research Institution, Children's Hospital of Chongqing Medical University, Chongqing, China ; Ministry of Education Key Laboratory of Child Development and Disorder, Children's Hospital of Chongqing Medical University, Chongqing, China.

Plos One
|March 4, 2014
PubMed

Insights

Ventilator-associated pneumonia (VAP) in neonates reduces lower respiratory tract microflora diversity within three days. Increased Klebsiella, Acinetobacter, and Streptococcus may indicate VAP development in infants on mechanical ventilation.

Area of Science:

  • Neonatal critical care
  • Microbiology
  • Genomics

Background:

  • Ventilator-associated pneumonia (VAP) is a significant cause of mortality in neonates requiring mechanical ventilation.
  • Defining the specific causes of VAP in this vulnerable population remains challenging.
  • Understanding the microbial shifts associated with VAP is crucial for diagnosis and treatment.

Purpose of the Study:

  • To investigate the dynamic changes in lower respiratory tract microflora diversity in neonates with and without VAP.
  • To identify potential microbial indicators for early VAP detection in infants with respiratory distress syndrome (RDS).

Main Methods:

  • Prospective study comparing neonates with RDS and VAP (experimental group) to those with RDS alone (control group).
  • Sputum samples collected at 1, 3, and 5 days post-intubation.
  • 16S rDNA gene sequencing (PCR amplification, DGGE, cloning, sequencing) to analyze microbial composition and diversity.
  • Bioinformatic analysis (BLAST) and statistical evaluation of microbial richness and diversity indices (Shannon-Wiener).

Main Results:

  • No significant differences in microbial genus ratios between VAP and non-VAP groups within the first day of ventilation.
  • Between days 1-3, VAP group showed increased ratios of Klebsiella spp., Acinetobacter spp., and Streptococcus spp., with decreased Serratia spp. and Achromobacter spp. compared to controls.
  • Microbial richness and Shannon-Wiener diversity index were lower in the VAP group from days 1-3.
  • After 3-5 days, microbial ratios shifted, with decreased Klebsiella spp., Acinetobacter spp., Serratia spp., and Achromobacter spp. in the VAP group.

Conclusions:

  • VAP is associated with reduced lower respiratory tract microflora diversity in neonates during the initial three days of mechanical ventilation.
  • Elevated levels of Klebsiella spp., Acinetobacter spp., and Streptococcus spp. in sputum may serve as early indicators of VAP in neonates.
  • Further research into these microbial shifts can inform diagnostic strategies and targeted interventions for VAP.

Related Concept Videos

Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
55
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
61
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
65